Nephrol Dial Transplant (1993) 8: 585-589
© 1993 European Renal Association-European Dialysis and Transplant Association
other
Factors influencing anaemia in dialysis patients. A special survey by the EDTA-ERA Registry
Leyenberg Ziekenhuis, The Hague, Netherlands Department of Public Health & Primary Care, Royal Free Hospital School of Medicine London, United Kingdom Department für Innere Medizin, Universität Basel Switzerland Department of Surgery 1 Sahlgrenska Sjukhuset, Goteborg, Sweden Medizinische Hochschule Hannover Germany Städtische Kliniken Fulda Germany Divisione di Nefrologia e Dialisi, Ospedale Pediatrico Bambino Gesu Rome, Italy EDTA Registry, St Thomas' Hospital United Kingdom Department of Surgery Sahlgrenska Sjukhuset, Göteborg, Sweden Renal Unit, St Thomas' Hospital London, United Kingdom
Correspondence and offprint requests to: Correspondence and offprint requests to: Dr N. P. Mallick, Chairman, EDTA Registry, St Thomas' Hospital, London SE1 7EH, UK
The European Dialysis and Transplantation AssociationEuropean Renal Association (EDTA-ERA) Registry conducted a special study on anaemia in dialysis patients because it seemed important to elucidate the various factors that influence the degree of anaemia and the use of regular transfusions in dialysis patients before the introduction of recombinant human erythropoietin (rHuEpo) for larger groups of patients. In a 20% sample of all patients recorded to have been dialysed throughout 1987, statistically significant associations could be found by multifactorial analysis between haemoglobin (Hb) concentration and age, sex, primary renal disease, type of treatment, hours of dialysis per week, and number of years on renal replacement therapy. The type of dialyser membrane did not seem to play a role (although there was weak evidence of an effect of the dialyser). Mean Hb concentration for dialysis patients differed between countries as did the transfusion policy. In view of the high costs of the rHuEpo treatment and potential side-effects, factors such as method of dialysis and hours of haemodialysis per week should be taken into consideration in the treatment of anaemia in dialysis patients.
Keywords: anaemia; sample study; EDTA Registry; dialysis patients; recombinant human erythropoietin (rHuEpo)
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
K.-U. Eckardt Anaemia correction--does the mode of dialysis matter? Nephrol. Dial. Transplant., September 1, 2000; 15(9): 1278 - 1280. [Full Text] [PDF] |
||||
![]() |
O. Ifudu Care of Patients Undergoing Hemodialysis N. Engl. J. Med., October 8, 1998; 339(15): 1054 - 1062. [Full Text] [PDF] |
||||

